Can a Director Pledge Their Shares? MAR Article 19 Notification, Closed Periods and the EU-UK Split.

Yes, a director can usually pledge their shares, but in the EU and the UK the pledge is disclosable. Under Article 19(7) of the Market Abuse Regulation (MAR), a pledge by a director or other person discharging managerial responsibilities (PDMR) is a notifiable transaction, and the custody-account exemption ends once a pledge is “designated to secure a specific credit facility” — as the pledge behind a dedicated share-backed facility normally is. Once the annual threshold is reached, the pledge is notified within three business days and then published.

The UK’s version of MAR kept Article 19(7) word for word; what differs is the threshold, the national figures and the closed-period exceptions the EU added through its Listing Act. This note is the European counterpart to Regulation U, Regulation X & the Purpose Statement and is general information, not legal or regulatory advice.

Does a director or PDMR have to notify a share pledge under MAR Article 19?

Yes, once the annual threshold is reached. Article 19(7)(a) states that the transactions to be notified “shall also include … the pledging or lending of financial instruments by or on behalf of a person discharging managerial responsibilities or a person closely associated with such a person”.

Article 3(1)(25) defines a PDMR as a member of the issuer’s administrative, management or supervisory body, or a senior executive with regular access to inside information and power to take managerial decisions, so non-executive and supervisory-board members are caught. Issuers whose instruments trade only on a multilateral or organised trading facility (MTF or OTF), such as a growth market, are covered too where they approved that trading or requested admission (Article 19(4)).

Recital 58 gives the reason: “the pledging of shares can result in a material and potentially destabilising impact on the company in the event of a sudden, unforeseen disposal.” Notification is required “where the pledge of the securities is made as part of a wider transaction in which the manager pledges the securities as collateral to gain credit from a third party.”

A pledge is not a sale, but MAR’s word for it is “transaction”. The notification states its nature under Article 19(6)(e), and under Article 19(6)(g) a pledge “whose terms provide for its value to change” is disclosed “together with its value at the date of the pledge”.

MAR is the floor, not the whole picture: an issuer’s share-dealing code or insider policy commonly requires clearance before dealing, and some restrict pledging outright.

When is a pledge in a custody account not notifiable, and when does it become notifiable?

A pledge that exists only because shares sit in a custody account is not notified; once it is designated to secure a specific credit facility, it is. The second subparagraph of Article 19(7) reads: “For the purposes of point (a), a pledge, or a similar security interest, of financial instruments in connection with the depositing of the financial instruments in a custody account does not need to be notified, unless and until such time that such pledge or other security interest is designated to secure a specific credit facility.”

The carve-out appears aimed at the general security interest custody terms often give the custodian. BaFin’s Issuer Guidelines (Emittentenleitfaden, Module C) take a similar approach: “Pure pledges are subject to the notification obligation as is any transfer by way of security”, but nothing is notified where a pledge arises only because an overdraft is drawn under a bank’s general terms and conditions. That is BaFin’s reading; other regulators’ guidance may differ.

A dedicated securities-backed facility normally sits on the far side of that line. Where shares already under a general custody pledge are later earmarked for a loan, “unless and until such time” points to the designation as the moment the exemption ends. Whether a particular charge, a title-transfer structure or a credit line secured only under a bank’s general terms is caught is a point for counsel.

Does a founder’s holding company, as a person closely associated, also have to notify a pledge?

Usually, yes. A company, trust or partnership that the director controls, or that is set up for their benefit, is a “person closely associated” (PCA), and notifying its pledge is its own obligation.

Beyond close family members, Article 3(1)(26) covers “a legal person, trust or partnership” whose managerial responsibilities the PDMR discharges, which the PDMR directly or indirectly controls, which is set up for the PDMR’s benefit, or whose economic interests are substantially equivalent to the PDMR’s. A personal holding company, family investment vehicle or trust holding a founder’s stake will often meet one of those tests.

The European Securities and Markets Authority (ESMA), in its Q&A on MAR (ESMA70-145-111), reads the first test as covering cases where a PDMR “takes part in or influences the decisions of another legal person … to carry out transactions in financial instruments of the issuer” (Q&A 7.7). Thresholds are counted separately: a PDMR’s transactions and those of closely associated persons “should not be aggregated” (Q&A 7.3).

So where a founder’s shares sit in a holding company, the pledgor is normally the vehicle and the notification is made in its name; whether a structure qualifies is a point for counsel. The financing structures are described in Founder Stock Loans, Controlling Shareholder Stock Loans and, for stakes held through a trust or holding company, Family-Office Stock Loans.

What is the PDMR notification threshold in the EU after the Listing Act, and which regulators have set a different figure?

EUR 20,000 a calendar year since 4 December 2024, unless the issuer’s regulator has raised it to EUR 50,000 or lowered it to EUR 10,000 under Article 19(9). ESMA’s list, last updated 21 May 2026, names five that have.

The Listing Act, Regulation (EU) 2024/2809, replaced Article 19(8): notification applies “once a total amount of EUR 20 000 has been reached within a calendar year”, calculated “by adding without netting all transactions”. Its Recital 74 calls this a rise “from EUR 5 000 to EUR 20 000”. Article 19(9) gives regulators two alternatives, EUR 50,000 or EUR 10,000, not a range, and ESMA publishes the list. As last updated on 21 May 2026, it records these figures (the dates come from each regulator’s own instrument):

• ·
  Malta — EUR 10,000, applied by the MFSA from 4 December 2024.
• ·
  Denmark — EUR 50,000, set by the Danish FSA (Finanstilsynet) from 1 July 2025.
• ·
  France — EUR 50,000, under Article 223-23 of the AMF General Regulation in the version in force since 27 December 2025.
• ·
  Germany — EUR 50,000, by BaFin general administrative act effective from 1 January 2026.
• ·
  Italy — EUR 50,000, by CONSOB resolution no. 23979 of 14 May 2026, in force from June 2026.

Elsewhere the default applies unless a regulator has since notified ESMA otherwise. Article 19(2) makes “the rules applicable to notifications” those of the Member State where the issuer is registered, so the figure that counts is normally that state’s (for an issuer registered outside the EU, its Transparency Directive home Member State’s), not that of the director’s country of residence. Major-holdings thresholds, which sit alongside MAR, are on the Germany stock loans and Italy stock loans market pages.

Two cautions: the threshold filters notification only, since the closed-period ban in Article 19(11) has none, and how a pledge is valued for the count is a point to confirm against the regulator’s guidance. The Article 19 changes applied from 4 December 2024, not from 5 June 2026, when most of the Listing Act’s Article 17 (inside information) changes took effect.

Is the UK MAR PDMR threshold different from the EU’s?

Yes. UK MAR still sets EUR 5,000 a calendar year, a quarter of the EU default, and the UK did not adopt the Listing Act’s changes to Article 19.

UK Article 19(8) applies notification “once a total amount of EUR 5 000 has been reached within a calendar year”. Article 19(9) lets the Financial Conduct Authority (FCA) raise the figure only to EUR 20,000, and the FCA’s Primary Market Bulletin No. 30, which lists pledging among the transactions to report, still states that “PDMR notifications must be made once aggregated transactions in a calendar year reach EUR 5,000.” UK MAR has no Article 19(12a), its Article 19(12) keeps the shares-only wording, and its deadlines run in working days, which exclude weekends, Christmas Day, Good Friday and England and Wales bank holidays.

The Financial Services and Markets Act 2023 provides for UK MAR’s eventual revocation; no date had been set at the time of writing. The FCA has said it will continue to have regard to relevant EU non-legislative material, so ESMA’s pre-2021 Q&As cited here remain relevant reading in London; LSE specifics are on the United Kingdom market page. Switzerland sits outside MAR: Article 5(2) of the SIX Directive on the Disclosure of Management Transactions, made under Article 56 of the SIX Listing Rules, states that pledges are not subject to the reporting obligation.

How quickly must a pledge be notified, and when must the issuer publish it?

Within three business days of the pledge, to the issuer and the regulator; the issuer then has two business days from receipt to publish. In the UK both periods run in working days.

Article 19(1) requires notification “promptly and no later than three business days after the date of the transaction”, to the issuer and, under Article 19(2), to the regulator of the Member State where the issuer is registered (in the UK, the FCA). Article 19(3) requires the issuer to publish “within two business days of receipt”, though national law may let the regulator publish instead.

Must the issuer announce a director’s share pledge? Under Article 19, once the threshold is reached and a notification made, yes: the published notification is the announcement, and because Article 19(6)(e) requires the nature of the transaction to be stated, it will show a pledge. Whether the pledge is also inside information under Article 17 is a separate, fact-specific question for the issuer. With no room to delay the announcement, what can be planned is the pledge date against the reporting calendar, the argument of Why Structuring Beats Pricing in Institutional Stock Loans.

Can a PDMR grant a share pledge during a MAR closed period?

Generally not, unless an exception under Article 19(12) or 19(12a) applies, and it is unsettled whether a pledge fits either. The closed-period ban is read as covering the same transactions as the notification duty, and a pledge is one of them.

Article 19(11) bars a PDMR from conducting “any transactions … directly or indirectly” in the issuer’s shares or debt instruments in the 30 calendar days before an interim or year-end report is announced. ESMA’s Q&A 7.9 confirms that the transactions barred in a closed period are the same as those notifiable under Article 19(1). Since Article 19(7) makes pledges notifiable “for the purposes of paragraph 1”, the two together are generally taken to bring the granting of a pledge within the ban. The ban applies only to the PDMR, the same answer notes; whether a pledge by the director’s own vehicle is an indirect transaction is a question for counsel.

Under Article 19(12) an issuer “may allow” a closed-period transaction case by case for exceptional circumstances “such as severe financial difficulty, which require the immediate sale” of shares or other instruments, or because of the characteristics of the trading, including “transactions where the beneficial interest in the relevant security does not change”. The first route is framed around a sale: Delegated Regulation (EU) 2016/522, as amended by Delegated Regulation (EU) 2026/788 from 5 August 2026, requires a reasoned request explaining why the sale is “the only reasonable alternative to obtain the necessary financing”, which does not readily fit granting a pledge. Whether a pledge, which leaves the director as beneficial owner, fits the second route is unsettled, and permission is discretionary.

Permission does not lift the insider dealing rules: under ESMA’s Q&A 7.8, “the general insider dealing provisions still apply”. In the structures this firm arranges, the holder is not in possession of inside information when the pledge is entered, and the firm does not request it, as noted in Can You Borrow Against Restricted or Lock-Up Shares?

Is a lender’s enforcement sale of a director’s pledged shares notifiable, and can it fall in a closed period?

On notification, BaFin says yes: its Issuer Guidelines treat realising pledged collateral as notifiable under Article 19, a view stated for the issuers it supervises but consistent with Recital 58. On the closed period, the position is unsettled: in the EU it turns on Article 19(12a) and the issuer’s case-by-case assessment, and the UK has no equivalent provision.

Article 19(12a) says an issuer “shall allow” closed-period transactions that do not relate to active investment decisions, that are based on predetermined terms, or that “result exclusively from external factors or actions of third parties”. None of the examples in Recital 76 is pledge enforcement; its references to “irrevocable arrangements entered into outside of a closed period” and to activities that “depend exclusively on external factors” are the closest analogies. In ESMA_QA_2303, answered on 18 February 2026, the European Commission said the issuer “has to verify that the relevant conditions are met in each individual case”, but that where they are met “the approval is to be considered automatic.”

No ESMA Q&A or Commission answer applies these rules to a lender’s enforcement, and whether such a sale is a transaction the director “conducts” under Article 19(11) at all is itself unsettled. If it is, the EU question is whether it results “exclusively” from a third party’s actions or involves no active investment decision by the director. A cure period, of the kind described in Margin Call Mechanics in Institutional Stock Loans, gives the director a chance to top up or repay first, but a director who could have cured and did not may find the sale treated as less than exclusively the lender’s doing; the point is one for the issuer and counsel at signing. In the UK, with no Article 19(12a), if the ban reaches the sale the only route is issuer permission under Article 19(12)(a), framed around the director’s own request in exceptional circumstances.

Does the lender have to make a major-holdings notification when it takes shares as collateral?

Not, in the ordinary pledge structure, merely by taking the pledge. Under Article 10(c) of the Transparency Directive (Directive 2004/109/EC) and, in the UK, DTR 5.2.1R(c) of the FCA’s Disclosure Guidance and Transparency Rules, votes on shares “lodged as collateral” are attributed to the lender only where it “controls the voting rights and declares its intention of exercising them”.

In the default structure described in Dividends and Corporate Actions in Stock Loans, voting authority typically remains with the borrower for the duration of the loan, so the pledge alone does not create that attribution. The position changes if the lender takes control of the votes and declares an intention to use them, or acquires the shares on enforcement; a transfer of title, or a financial instrument held by the lender, needs its own analysis under national thresholds such as DTR 5. The MAR notification is the director’s, or the vehicle’s; any major-holdings notification is the lender’s own.

What does this mean for a director arranging a share-backed facility?

Five practical points follow for a director or a director’s vehicle.

• i
  The pledge is a transaction. It is notifiable under Article 19(7)(a) once the threshold is reached; the custody-account carve-out does not reach a pledge designated to a specific facility.
• ii
  The pledgor and the dealing code come first. A holding company or trust is normally a person closely associated, with its own duty and threshold count, and the issuer’s dealing code may require clearance or restrict pledging.
• iii
  The director checks the applicable threshold. It normally follows the issuer’s Member State of registration, not the director’s residence.
• iv
  The director maps the timetable against the reporting calendar. Three business days to notify, two for the issuer to publish, and a 30-day closed period before each interim and year-end announcement.
• v
  The director and counsel consider enforcement at signing. If the closed-period ban reaches an enforcement sale at all, the EU route is Article 19(12a) and the UK route is issuer permission.

None of this is legal or regulatory advice or a substitute for counsel; its purpose is to put these questions on the table while the facility is still being structured, not after the pledge is granted.